Table of Contents Author Guidelines Submit a Manuscript
Journal of Analytical Methods in Chemistry
Volume 2014, Article ID 352698, 7 pages
http://dx.doi.org/10.1155/2014/352698
Research Article

Validated Method for the Determination of Piroxicam by Capillary Zone Electrophoresis and Its Application to Tablets

Department of Analytical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Turkey

Received 8 July 2014; Revised 21 August 2014; Accepted 21 August 2014; Published 9 September 2014

Academic Editor: Sibel A. Ozkan

Copyright © 2014 Arın Gül Dal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Starek and J. Krzek, “A review of analytical techniques for determination of oxicams, nimesulide and nabumetone,” Talanta, vol. 77, no. 3, pp. 925–942, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Macià, F. Borrull, M. Calull, and C. Aguilar, “Capillary electrophoresis for the analysis of non-steroidal anti-inflammatory drugs,” TrAC—Trends in Analytical Chemistry, vol. 26, no. 2, pp. 133–153, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. A. S. Amin, “Spectrophotometric determination of piroxicam and tenoxicam in pharmaceutical formulations using alizarin,” Journal of Pharmaceutical and Biomedical Analysis, vol. 29, no. 4, pp. 729–736, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. A. S. Amin, H. A. Dessouki, and K. M. Khalil, “Indirect spectrophotometric determination of piroxicam and tenoxicam through oxidation with potassium permanganate,” Bulletin of the Chemical Society of Ethiopia, vol. 24, no. 1, pp. 121–126, 2010. View at Google Scholar · View at Scopus
  5. A. Klopas, I. Panderi, and M. Parissi-Poulou, “Determination of piroxicam and its major metabolite 5-hydroxypiroxicam in human plasma by zero-crossing first-derivative spectrophotometry,” Journal of Pharmaceutical and Biomedical Analysis, vol. 17, no. 3, pp. 515–524, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. B. S. Nagaralli, J. Seetharamappa, and M. B. Melwanki, “Sensitive spectrophotometric methods for the determination of amoxycillin, ciprofloxacin and piroxicam in pure and pharmaceutical formulations,” Journal of Pharmaceutical and Biomedical Analysis, vol. 29, no. 5, pp. 859–864, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. A. J. Nepote, L. Vera-Candiotti, M. R. Williner, P. C. Damiani, and A. C. Olivieri, “Development and validation of chemometrics-assisted spectrophotometry and micellar electrokinetic chromatography for the determination of four-component pharmaceuticals,” Analytica Chimica Acta, vol. 489, no. 1, pp. 77–84, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. M. I. Pascual-Reguera, M. J. Ayora-Canada, and M. S. Castro Ruiz, “Determination of piroxicam by solid-phase spectrophotometry in a continuous flow system,” European Journal of Pharmaceutical Sciences, vol. 15, no. 2, pp. 179–183, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Basan, N. G. Göger, N. Ertaş, and M. T. Orbey, “Quantitative determination of piroxicam in a new formulation (piroxicam-β-cyclodextrin) by derivative UV spectrophotometric method and HPLC,” Journal of Pharmaceutical and Biomedical Analysis, vol. 26, no. 2, pp. 171–178, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. J. A. Arancibia and G. M. Escandar, “Two different strategies for the fluorimetric determination of piroxicam in serum,” Talanta, vol. 60, no. 6, pp. 1113–1121, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. G. M. Escandar, A. J. Bystol, and A. D. Campiglia, “Spectrofluorimetric method for the determination of piroxicam and pyridoxine,” Analytica Chimica Acta, vol. 466, no. 2, pp. 275–283, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. K. C. Ramesh, B. G. Gowda, J. Seetharamappa, and J. Keshavayya, “Indirect spectrofluorimetric determination of piroxicam and propranolol hydrochloride in bulk and pharmaceutical preparations,” Journal of Analytical Chemistry, vol. 58, no. 10, pp. 933–936, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Bartsch, A. Eiper, and H. Kopelent-Frank, “Stability indicating assays for the determination of piroxicam—comparison of methods,” Journal of Pharmaceutical and Biomedical Analysis, vol. 20, no. 3, pp. 531–541, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Crecelius, M. R. Clench, D. S. Richards, and V. Parr, “Quantitative determination of piroxicam by TLC-MALDI TOF MS,” Journal of Pharmaceutical and Biomedical Analysis, vol. 35, no. 1, pp. 31–39, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Amanlou and A. R. Dehpour, “Rapid method for the determination of piroxicam in rat plasma using high-performance liquid chromatography,” Journal of Chromatography B, vol. 696, no. 2, pp. 317–319, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. A. D. de Jager, H. Ellis, H. K. L. Hundt, K. J. Swart, and A. F. Hundt, “High-performance liquid chromatographic determination with amperometric detection of piroxicam in human plasma and tissues,” Journal of Chromatography B: Biomedical Sciences and Applications, vol. 729, no. 1-2, pp. 183–189, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Yritia, P. Parra, J. M. Fernández, and J. M. Barbanoj, “Piroxicam quantitation in human plasma by high-performance liquid chromatography with on- and off-line solid-phase extraction,” Journal of Chromatography A, vol. 846, no. 1-2, pp. 199–205, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Y. Ji, H. W. Lee, Y. H. Kim, D. W. Jeong, and H. S. Lee, “Simultaneous determination of piroxicam, meloxicam and tenoxicam in human plasma by liquid chromatography with tandem mass spectrometry,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 826, no. 1-2, pp. 214–219, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Dadashzadeh, A. M. Vali, and N. Rezagholi, “LC determination of piroxicam in human plasma,” Journal of Pharmaceutical and Biomedical Analysis, vol. 28, no. 6, pp. 1201–1204, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Doliwa, S. Santoyo, M. A. Campanero, and P. Ygartua, “Sensitive LC determination of piroxicam after in vitro transdermal permeation studies,” Journal of Pharmaceutical and Biomedical Analysis, vol. 26, no. 4, pp. 531–537, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. X.-Y. Song, Y.-P. Shi, and J. Chen, “A novel extraction technique based on carbon nanotubes reinforced hollow fiber solid/liquid microextraction for the measurement of piroxicam and diclofenac combined with high performance liquid chromatography,” Talanta, vol. 100, pp. 153–161, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Shirako, M. Kawasaki, K. Komine et al., “Simultaneous determination for oxicam non-steroidal anti-inflammatory drugs in human serum by liquid chromatography-tandem mass spectrometry,” Forensic Science International, vol. 227, no. 1–3, pp. 100–102, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Dowling and E. Malone, “Analytical strategy for the confirmatory analysis of the non-steroidal anti-inflammatory drugs firocoxib, propyphenazone, ramifenazone and piroxicam in bovine plasma by liquid chromatography tandem mass spectrometry,” Journal of Pharmaceutical and Biomedical Analysis, vol. 56, no. 2, pp. 359–365, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. Y.-L. Chen and S.-M. Wu, “Capillary zone electrophoresis for simultaneous determination of seven nonsteroidal anti-inflammatory drugs in pharmaceuticals,” Analytical and Bioanalytical Chemistry, vol. 381, no. 4, pp. 907–912, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. C. M. Boone, J. W. Douma, J. P. Franke, R. A. De Zeeuw, and K. Ensing, “Screening for the presence of drugs in serum and urine using different separation modes of capillary electrophoresis,” Forensic Science International, vol. 121, no. 1-2, pp. 89–96, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Fillet, I. Bechet, V. Piette, and J. Crommen, “Separation of nonsteroidal anti-inflammatory drugs by capillary electrophoresis using nonaqueous electrolytes,” Electrophoresis, vol. 20, pp. 1907–1915, 1999. View at Google Scholar
  27. M. G. Donato, W. Baeyens, W. Van Den Bossche, and P. Sandra, “The determination of non-steroidal antiinflammatory drugs in pharmaceuticals by capillary zone electrophoresis and micellar electrokinetic capillary chromatography,” Journal of Pharmaceutical and Biomedical Analysis, vol. 12, no. 1, pp. 21–26, 1994. View at Publisher · View at Google Scholar · View at Scopus
  28. “ICH, Q2(R1), Harmonized Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology,” in International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, 2005.
  29. United States Pharmacopoeia/National Formulary, Pharmacopeial Convention, Rockville, Md, USA, 24th edition, 2000.